High-Level Soluble Expression and One-step Purification of HTLV-I P19 Protein in Escherichia coli by Fusion Expression
,
Abstract
Expression of HTLV-I p19 protein in an Escherichia coli expression system always leads to the formation of inclusion body. Solubilisation and refolding of the inclusion bodies is complex, time consuming and difficult during large-scale preparation. This study aimed to express and purify a soluble form of recombinant HTLV-I p19 protein in an E. coli expression system. The synthetic DNA encoding the p19 was subcloned into a pGS21a vector along with a His-GST solubility/purification tag. The recombinant pGS21a-p19 vector was then transformed into chemically competent E. coli BL21 (DE3) cells, and expression of the recombinant His-GST-p19 protein was induced by IPTG. Expression and distribution of the His-GST-p19 protein in soluble and insoluble fractions were evaluated using SDS-PAGE. Antigenicity of the His-GST-p19 protein was evaluated using ELISA after purifying the protein using Ni-NTA affinity chromatography, then compared to the results of synthetic immunodominant p19 peptide ELISA. The fusion His-GST-p19 protein accounted for 30% of the total cellular proteins. The SDS-PAGE results indicated that approximately 50% of the expressed His-GST-p19 proteins were soluble and accounted for 50% of the total soluble proteins. ELISA showed that the His-GST tag did not impair the antigenicity of the p19 protein and that the fusion protein reacted with HTLV-I antibodies in a concentration-dependent manner. The results of His-GST-p19 ELISA indicated that specificity of p19 reactivity was compatible to the results of p19 peptide ELISA. Combination of key strategies for the soluble expresion of proteins, like fusion with solubility/purification tags, low IPTG concentration and induction at low temperature, provide an efficient and facile platform for producing soluble HTLV-I p19 protein.
1. Mahieux R, Gessain A. Adult T-cell leukemia/lymphoma and HTLV-1. Curr Hematol Malig Rep. 2007; 2(4):257-64.
2. Zarnagh HH, Ravanshad M, Pourfatollah AA, Rasaee MJ. Expression and Purification of a Novel Computationally Designed Antigen for Simultaneously Detection of HTLV-1 and HBV Antibodies. Iranian Journal of Allergy, Asthma and Immunology 2014, (under printing).
3. Safabakhsh H, Jalalian M, Karimi G. Seroepidemiology of Human T-Cell Lymphotropic Virus Type-1 (HTLV-1) in Mashhad. Glob J Health Sci 2014; 6(5).
4. Rosano GL, Ceccarelli EA. Recombinant protein expression in Escherichia coli: advances and challenges. Front Microbiol 2014; 5(172).
5. Zhang B, Liu D, Bao Z, Chen B, Li C, Jiang H, et al.High level soluble expression, one-step purification and characterization of HIV-1 p24 protein. Virol J 2011;8(316):8-316.
6. Costa S, Almeida A, Castro A, Domingues L. Fusion tags for protein solubility, purification and immunogenicity in Escherichia coli: the novel Fh8 system. Front Microbiol 2014; 5(63).
7. Rabhi-Essafi I, Sadok A, Khalaf N, Fathallah DM. A strategy for high-level expression of soluble and functional human interferon alpha as a GST-fusion protein in E. coli. Protein Eng Des Sel 2007; 20(5):201-9.
8. Yu H, Ma Q, Lin J, Sun YF, Zheng F. Expression and purification of GST-FHL2 fusion protein. Genet Mol Res.2013; 12(4):6372-8.
9. Itamura S, Shigesada K, Imai M, Kobayashi N, Hamakado T, Harada T, et al. Expression of the gag gene of human T-cell leukemia virus type I in Escherichia coli and its diagnostic use. Gene 1985; 38(1-3):57-64.
10. Smith DB, Johnson KS. Single-step purification of polypeptides expressed in Escherichia coli as fusion with glutathione-S-transferase. Gene 1988; 67(1):31-40.
11. Malhotra A. Tagging for protein expression. Methods in Enzymology 2009; 463:239-58.
12. Dummler A, Lawrence AM, de Marco A. Simplified screening for the detection of soluble fusion constructs expressed in E. coli using a modular set of vectors. Microb Cell Fact 2005; 4:34.
13. Cabrita LD, Dai W, Bottomley SP. A family of E. coli expression vectors for laboratory scale and high throughput soluble protein production. BMC Biotechnol 2006; 6:12.
14. Kim S, Lee SB. Soluble expression of archaeal proteins in Escherichia coli by using fusion-partners. Protein Expr Purif 2008; 62(1):116-9.
15. Takakura Y, Katayama S, Nagata Y. High-level expression of tamavidin 2 in human cells by codon-usage optimization. Biosci Biotechnol Biochem 2014; 15:1-7.
16. Ray M, Mishra P, Das P, Sabat SC. Expression and purification of soluble bio-active rice plant catalase-A from recombinant Escherichia coli. J Biotechnol 2012;157(1):12-9.
17. Hammarstrom M, Hellgren N, van Den Berg S, Berglund H, Hard T. Rapid screening for improved solubility of small human proteins produced as fusion proteins in Escherichia coli. Protein Sci. 2002; 11(2):313-21.
18. Hammarstrom M, Woestenenk EA, Hellgren N, Hard T, Berglund H. Effect of N-terminal solubility enhancing fusion proteins on yield of purified target protein. J Struct Funct Genomics 2006; 7(1):1-14.
19. Kohl T, Schmidt C, Wiemann S, Poustka A, Korf U.Automated production of recombinant human proteins as resource for proteome research. Proteome Sci. 2008;6(4):1477-5956.
20. Klein M, Kötz A, Bernardo K, Krönke M. Detection of Chlamydia pneumoniae-specific antibodies binding to the VD2 and VD3 regions of the major outer membrane protein. Journal of Clinical Microbiology 2003;41(5):1957-62.
21. Lecordier L, Fourmaux M-P, Mercier C, Dehecq E, Masy E, Cesbron-Delauw M-F. Enzyme-linked immunosorbent assays using the recombinant dense granule antigens GRA6 and GRA1 of Toxoplasma gondii for detection of immunoglobulin G antibodies. Clinical and Diagnostic Laboratory Immunology 2000; 7(4):607-11.
22. Lang D, Hinderer W, Rothe M, Sonneborn H-H, Neipel F, Raab M, et al. Comparison of the immunoglobulin-G- specific seroreactivity of different recombinant antigens of the human herpesvirus 8. Virology 1999; 260(1):47-54.
23. Li J, Zhang W-B, McManus DP. Recombinant antigens for immunodiagnosis of cystic echinococcosis. Biological Procedures Online 2004; 6(1):67-77.
| Files | ||
| Issue | Vol 14, No 6 (2015) | |
| Section | Original Article(s) | |
| Keywords | ||
| Antigenicity His-GST-tag HTLV-I capsid Purification | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
